Kendall Peterson
Dallas, TXNPI 1265890057
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $167,296 of the $176,324 with a category attached, or 94.9%. Galderma Laboratories, L.p. accounts for 94.9% of it on its own, with 3 other manufacturers making up the rest.
Across 187 payments — averaging $942.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$167K
- Revance Therapeutics, Inc.$8K
- AbbVie$695
- Pacira Pharmaceuticals Incorporated$27
What the payments were for
- Speaking & faculty fees$167,29695%
- Travel & lodging$5,8233%
- Food & beverage$3,2052%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 170 | $167,312 |
| Revance Therapeutics, Inc. | 8 | $8,290 |
| AbbVie(2 entities) | 8 | $695 |
| Pacira Pharmaceuticals Incorporated | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.